These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency: when is it indicated, what is the goal and how to do it? Domínguez-Muñoz JE Adv Med Sci; 2011; 56(1):1-5. PubMed ID: 21450558 [TBL] [Abstract][Full Text] [Related]
3. Chronic pancreatitis and persistent steatorrhea: what is the correct dose of enzymes? Domínguez-Muñoz JE Clin Gastroenterol Hepatol; 2011 Jul; 9(7):541-6. PubMed ID: 21377551 [TBL] [Abstract][Full Text] [Related]
9. Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis. Dutta SK; Hubbard VS; Appler M Dig Dis Sci; 1988 Oct; 33(10):1237-44. PubMed ID: 3168696 [TBL] [Abstract][Full Text] [Related]
10. [Differential therapy of exocrine pancreatic insufficiency--current aspects and future prospects of substitution therapy with pancreatic enzymes]. Löser C; Fölsch UR Z Gastroenterol; 1995 Dec; 33(12):715-22. PubMed ID: 8585255 [TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Dutta SK; Rubin J; Harvey J Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746 [TBL] [Abstract][Full Text] [Related]
12. A primer on exocrine pancreatic insufficiency, fat malabsorption, and fatty acid abnormalities. Alkaade S; Vareedayah AA Am J Manag Care; 2017 Jul; 23(12 Suppl):S203-S209. PubMed ID: 28727474 [TBL] [Abstract][Full Text] [Related]
13. Maldigestion associated with exocrine pancreatic insufficiency: implications of gastrointestinal physiology and properties of enzyme preparations for a cause-related and patient-tailored treatment. Bruno MJ; Haverkort EB; Tytgat GN; van Leeuwen DJ Am J Gastroenterol; 1995 Sep; 90(9):1383-93. PubMed ID: 7661155 [TBL] [Abstract][Full Text] [Related]
15. Chronic pancreatitis: maldigestion, intestinal ecology and intestinal inflammation. Pezzilli R World J Gastroenterol; 2009 Apr; 15(14):1673-6. PubMed ID: 19360910 [TBL] [Abstract][Full Text] [Related]
16. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three-way crossover study. Domínguez-Muñoz JE; Iglesias-García J; Iglesias-Rey M; Figueiras A; Vilariño-Insua M Aliment Pharmacol Ther; 2005 Apr; 21(8):993-1000. PubMed ID: 15813835 [TBL] [Abstract][Full Text] [Related]
17. Study of the gastrointestinal bioavailability of a pancreatic extract product (Zenpep) in chronic pancreatitis patients with exocrine pancreatic insufficiency. Lieb JG; Patel D; Karnik N; Toskes PP Pancreatology; 2020 Sep; 20(6):1092-1102. PubMed ID: 32800653 [TBL] [Abstract][Full Text] [Related]
18. Enzyme therapy for malabsorption in exocrine pancreatic insufficiency. Roberts IM Pancreas; 1989; 4(4):496-503. PubMed ID: 2668933 [TBL] [Abstract][Full Text] [Related]